TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36260487

Group type: EXPERIMENTAL
Intervention: 4-strand hamstring autograft
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: 5-strand hamstring autograft
Number of subjects: 399
Study: 34429733

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program conducted in 8 sessions, once every week, each session lasting 2.5 hours.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 67
Study: 33278743

Group type: EXPERIMENTAL
Intervention: Transdiagnostic digital intervention
Number of subjects: 632
Study: 33028030

Group type: EXPERIMENTAL
Intervention: First-person narrative message
Number of subjects: 525

Group type: COMPARATOR
Intervention: Third-person narrative message
Number of subjects: 525
Study: 33147327

Group type: COMPARATOR
Intervention: Azithromycin 1 g single dose
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 296
Study: 32004648

Group type: EXPERIMENTAL
Intervention: FMX103 1.5% topical minocycline foam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 34689347

Group type: EXPERIMENTAL
Intervention: Motor sequence learning under explicit learning conditions
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Motor sequence learning under implicit learning conditions
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dual-task (DT) conditions with subtracting sevens
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dual-task (DT) conditions with verbal fluency
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dual-task (DT) conditions with vigilance
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (HC)
Number of subjects: 37
Study: 33966407

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 164

Group type: COMPARATOR
Intervention: Basic nursing intervention
Number of subjects: 164
Study: 33098815

Group type: EXPERIMENTAL
Intervention: Gradient boosted model
Number of subjects: 303678

Group type: COMPARATOR
Intervention: Logistic regression model
Number of subjects: 303678
Study: 32492988

Group type: EXPERIMENTAL
Intervention: Electronic vaping cigarettes (EVC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heat-not-burn cigarettes (HNBC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both EVC and HNBC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EVC
Number of subjects: 20
Study: 34431238

Group type: EXPERIMENTAL
Intervention: The Good Life intervention (experimental group)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Wait-list/no-treatment control group
Number of subjects: 182
Study: 33669440

Group type: EXPERIMENTAL
Intervention: HCWs in fever clinics
Number of subjects: 1378

Group type: EXPERIMENTAL
Intervention: Role conflict and ambiguity
Number of subjects: 1378

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 1378

Group type: COMPARATOR
Intervention: Regular primary healthcare centers
Number of subjects: 1378
Study: 32173633

Group type: EXPERIMENTAL
Intervention: Dual trigger group (GnRH agonist and rHCG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: rHCG group (control)
Number of subjects: 0
Study: 35924398

Group type: EXPERIMENTAL
Intervention: Non-ionic colloidal silver solution rinse for 6 months as an adjunct to standard oral hygiene regimen
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard oral hygiene regimen
Number of subjects: 80
Study: 32690763

Group type: EXPERIMENTAL
Intervention: v-gel SGAD
Number of subjects: 14

Group type: COMPARATOR
Intervention: EEI
Number of subjects: 14
Study: 33231778

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) applied to wound surface for 5 minutes after incision
Number of subjects: 76

Group type: COMPARATOR
Intervention: Normal saline control applied to wound surface for 5 minutes after incision
Number of subjects: 76
Study: 36377012

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham-Kinesio taping
Number of subjects: 57
Study: 32076985

Group type: EXPERIMENTAL
Intervention: Individual acupuncture therapy
Number of subjects: 779

Group type: COMPARATOR
Intervention: Group acupuncture therapy
Number of subjects: 779
Study: 35609328

Group type: EXPERIMENTAL
Intervention: FED (0.25 g·kg‐1 protein and 0.75 g·kg‐1 carbohydrate with 5% l‐[1‐13C]leucine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EXFED (0.25 g·kg‐1 protein and 0.75 g·kg‐1 carbohydrate with 5% l‐[1‐13C]leucine after resistance exercise)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FED
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EXFED
Number of subjects: 100

Group type: COMPARATOR
Intervention: FAST (only the tracer)
Number of subjects: 100
Study: 33683573

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 36
Study: 35840300

Group type: EXPERIMENTAL
Intervention: Family doctor-led intervention including usual care, medication reminder, 4-week plan, weekly phone interview, and monthly interview.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional medical services and health education (Control group).
Number of subjects: 0
Study: 33557578

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 803

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 803
Study: 36279218

Group type: EXPERIMENTAL
Intervention: Mindfulness app
Number of subjects: 152

Group type: COMPARATOR
Intervention: Mood-monitoring control
Number of subjects: 152
Study: 33273210

Group type: EXPERIMENTAL
Intervention: Continue ART (CTART)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Discontinue ART
Number of subjects: 557
Study: 35984107

Group type: EXPERIMENTAL
Intervention: Palbociclib + exemestane
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Palbociclib + letrozole
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Palbociclib + fulvestrant
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Palbociclib + toremifene
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Palbociclib + anastrozole
Number of subjects: 186

Group type: COMPARATOR
Intervention: Everolimus pre-treated group
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Everolimus-naïve group
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: After propensity score matching
Number of subjects: 186
Study: 34226683

Group type: EXPERIMENTAL
Intervention: Sensorimotor training (SMT) and resistance training (RT)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 170
Study: 32526149

Group type: EXPERIMENTAL
Intervention: Coated devices (ETT, CVC, UC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Uncoated devices (ETT, CVC, UC)
Number of subjects: 103
Study: 36207154

Group type: EXPERIMENTAL
Intervention: Active medication (multimodal analgesic solution)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 28
Study: 33788329

Group type: EXPERIMENTAL
Intervention: Two-session brief intervention (BI)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Six-session combined intervention (CoI)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 426
Study: 32780742

Group type: EXPERIMENTAL
Intervention: Agent-based dynamic process with gendered status concerns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of agents less influenced by relative status rank
Number of subjects: 0
Study: 35474007

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (FTD/TPI)
Number of subjects: 150
Study: 32687801

Group type: EXPERIMENTAL
Intervention: IN-REC-SUR-E (intubate-recruit-surfactant-extubate)
Number of subjects: 218

Group type: COMPARATOR
Intervention: IN-SUR-E (intubate-surfactant-extubate)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: IN-REC-SUR-E
Number of subjects: 218

Group type: COMPARATOR
Intervention: IN-SUR-E
Number of subjects: 218
Study: 34861170

Group type: EXPERIMENTAL
Intervention: Pimavanserin (20 mg starting dosage, adjustable to 34 mg or 10 mg within the first 8 weeks, administered orally once daily)
Number of subjects: 403
Study: 34302927

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Biphasic Positive Airway Pressure with Assisted Spontaneous Ventilation (BIPAP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 30
Study: 35798338

Group type: EXPERIMENTAL
Intervention: Training regimen with a live rat every 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training regimen with a live rat every 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training regimen with a live rat every 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 32455486

Group type: EXPERIMENTAL
Intervention: Comparative approach
Number of subjects: 25

Group type: COMPARATOR
Intervention: Morphologic approach
Number of subjects: 25
Study: 32461526

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate high-monounsaturated fatty acid (LC/HM) formula
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control standard formula
Number of subjects: 10
Study: 35859621

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amino Acid Combination (AA) (3 g of L-arginine-hydrochloride and 8 g of L-citrulline-malate)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE) (300 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resting vs. Post-exercise Measurements
Number of subjects: 30
Study: 33384217

Group type: EXPERIMENTAL
Intervention: Hybrid Training System (HTS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: General Rotator Cuff Exercise with Elastic Band (EB)
Number of subjects: 20
Study: 33177278

Group type: EXPERIMENTAL
Intervention: Ascidian-derived plasmalogen (1 mg as plasmalogen) for 12 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo food for 12 weeks
Number of subjects: 49
Study: 36453165

Group type: EXPERIMENTAL
Intervention: Sleep-Opt-In
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy Living attention control
Number of subjects: 14
Study: 33416271

Group type: EXPERIMENTAL
Intervention: 30-min rest protocol
Number of subjects: 9

Group type: COMPARATOR
Intervention: multivisit protocol
Number of subjects: 9
Study: 33211738

Group type: EXPERIMENTAL
Intervention: Evidence-based practices (EBPs) in dispensing OTC medications
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Question: 'Describe your symptoms'
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Factors affecting EBP application
Number of subjects: 227
Study: 35733163

Group type: EXPERIMENTAL
Intervention: AT+Vit D
Number of subjects: 48

Group type: COMPARATOR
Intervention: AT
Number of subjects: 48

Group type: COMPARATOR
Intervention: Vit D
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study: 34314347

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure therapy
Number of subjects: 548

Group type: COMPARATOR
Intervention: Control group (AHI < 5 events/h)
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 548
Study: 33512328

Group type: EXPERIMENTAL
Intervention: Deliberative interaction style CA
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Paternalistic interaction style CA
Number of subjects: 88
Study: 32866625

Group type: EXPERIMENTAL
Intervention: Paclitaxel and Trastuzumab (TH)
Number of subjects: 1770

Group type: COMPARATOR
Intervention: Anthracycline/Cyclophosphamide/Taxane (ACTH) or Taxane/Carboplatin (TCH)
Number of subjects: 1770
Study: 35363271

Group type: EXPERIMENTAL
Intervention: Jumpstart communication-priming intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care with baseline questionnaires (control)
Number of subjects: 150
Study: 32301644

Group type: EXPERIMENTAL
Intervention: dispatcher‐assisted telephone CPR combined with the smartphone-application (telephone + app‐group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: dispatcher‐assisted telephone CPR with additional verbal motivation and a metronome (telephone + motivation-group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: dispatcher‐assisted telephone CPR (telephone-group)
Number of subjects: 150
Study: 32929906

Group type: EXPERIMENTAL
Intervention: Percutaneous autogenous cBMA+PRP injection
Number of subjects: 66

Group type: COMPARATOR
Intervention: Percutaneous autogenous bone marrow blood injection (Control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 32996239

Group type: EXPERIMENTAL
Intervention: Chewing gum (10 minutes, six times a day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no chewing gum)
Number of subjects: 44
Study: 36233611

Group type: EXPERIMENTAL
Intervention: Ellagic Acid (500 mg orally twice a day for 12 weeks)
Number of subjects: 32
Study: 34967732

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB) in combination with intra-articular corticosteroid injection (IAI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intra-articular corticosteroid injection (IAI) only
Number of subjects: 40
Study: 35000456

Group type: EXPERIMENTAL
Intervention: Intracoronary epinephrine
Number of subjects: 201

Group type: COMPARATOR
Intervention: Intracoronary adenosine
Number of subjects: 201
Study: 33449337

Group type: EXPERIMENTAL
Intervention: ALN-EX (effervescent buffered solution of 70 mg alendronate)
Number of subjects: 360

Group type: COMPARATOR
Intervention: ALN-T (alendronate tablets)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: ALN-EX
Number of subjects: 360

Group type: COMPARATOR
Intervention: ALN-T
Number of subjects: 360
Study: 35985477

Group type: EXPERIMENTAL
Intervention: SITA Faster (SFR)
Number of subjects: 74

Group type: COMPARATOR
Intervention: SITA Standard (SS)
Number of subjects: 74
Study: 34503827

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided catheterisation
Number of subjects: 136

Group type: COMPARATOR
Intervention: Landmark-guided catheterisation
Number of subjects: 136
Study: 33729273

Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA) for both CEA and CABG
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cervical block anaesthesia (CB) for CEA followed by general anaesthesia (GA) for CABG
Number of subjects: 34
Study: 33508736

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Complete response (CR) after CCRT
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: CR after CCRT followed by ACT
Number of subjects: 88
Study: 36471982

Group type: EXPERIMENTAL
Intervention: Chinese medicine as adjuvant therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Efficacy on TCM syndromes
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Main outcome indicators
Number of subjects: 34
Study: 33934471

Group type: EXPERIMENTAL
Intervention: 4% capryloyl glycine and 1% glycine soy‐fermented extract cream (product A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo cream (product B)
Number of subjects: 12
Study: 36352788

Group type: EXPERIMENTAL
Intervention: Open-glottis (OG) pushing
Number of subjects: 250

Group type: COMPARATOR
Intervention: Closed-glottis (CG) pushing
Number of subjects: 250
Study: 34516703

Group type: EXPERIMENTAL
Intervention: Naringenin (100 mg capsules, twice a day for 4 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (placebo capsules, twice a day for 4 weeks)
Number of subjects: 44
Study: 35733127

Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive behavioral therapy (TCBT) - 10 sessions
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group - one session on relaxation and stress-management techniques
Number of subjects: 35
Study: 33218555

Group type: EXPERIMENTAL
Intervention: Physical therapy and rehabilitation (PTR) combined with osteopathic management (OSTEO group)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Physical therapy and rehabilitation (PTR) only (PTR group)
Number of subjects: 18
Study: 34963346

Group type: EXPERIMENTAL
Intervention: Intervention focused on enhancing the quality of the nutrition environment, self‐efficacy, and practices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention focused on improving providers' environmental health literacy, self‐efficacy, and practices
Number of subjects: 0
Study: 34650305

Group type: EXPERIMENTAL
Intervention: Solid silicon stamp
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Transparent silicon stamp
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (indirect CAD/CAM composite resin restoration)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: General composite resin (2 mm occlusal veneer)
Number of subjects: 54
Study: 35796739

Group type: EXPERIMENTAL
Intervention: GnRH antagonist regimen
Number of subjects: 192

Group type: COMPARATOR
Intervention: Short GnRH agonist regimen
Number of subjects: 192
Study: 33127531

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: AKI Stage 1
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: AKI Stage 2
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: AKI Stage 3
Number of subjects: 854
Study: 35298917

Group type: EXPERIMENTAL
Intervention: Levothyroxine (0.5-1.0 μg/kg bodyweight, orally once daily until the end of pregnancy)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo (orally once daily until the end of pregnancy)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 32485325

Group type: EXPERIMENTAL
Intervention: Pharmacy liaison with training in motivational interviewing and as a patient navigator who systematically screens for health‐related social needs and provides targeted navigation services.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (pharmacy liaison to promote medication adherence).
Number of subjects: 0
Study: 34728000

Group type: EXPERIMENTAL
Intervention: Nutrient profiling tax condition based on Nutri‐Score
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: SSB tax condition
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control condition with regular food prices
Number of subjects: 394
Study: 32910097

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 1
Study: 36006011

Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297

Group type: COMPARATOR
Intervention: Filgotinib vs. intravenous vedolizumab
Number of subjects: 297

Group type: COMPARATOR
Intervention: Filgotinib vs. subcutaneous vedolizumab
Number of subjects: 297

Group type: COMPARATOR
Intervention: Filgotinib vs. tofacitinib
Number of subjects: 297
Study: 34308834

Group type: EXPERIMENTAL
Intervention: 5 mg generic solifenacin succinate tablet
Number of subjects: 56

Group type: COMPARATOR
Intervention: 5 mg solifenacin succinate tablets (vesicare)
Number of subjects: 56
Study: 33412065

Group type: EXPERIMENTAL
Intervention: New two-qubit gate scheme using fixed-frequency qubits and a tunable coupler; controlled-Z gate produced in 30 ns with a high fidelity of 99.5%.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Error analysis of the gate scheme; coherence limited errors identified.
Number of subjects: 0
Study: 35046058

Group type: EXPERIMENTAL
Intervention: venetoclax + azacitidine
Number of subjects: 109

Group type: COMPARATOR
Intervention: azacitidine
Number of subjects: 109
Study: 34472130

Group type: EXPERIMENTAL
Intervention: Higher number of cigarettes per day
Number of subjects: 12308

Group type: EXPERIMENTAL
Intervention: Lifetime smoking index
Number of subjects: 12308

Group type: EXPERIMENTAL
Intervention: Drinks per week
Number of subjects: 12308
Study: 34116741

Group type: EXPERIMENTAL
Intervention: Thirty‐minute, self‐paced online training in English or Spanish with ongoing technical assistance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thirty‐minute, self‐paced online training in English or Spanish without ongoing technical assistance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 0
Study: 35532908

Group type: EXPERIMENTAL
Intervention: Methylcobalamin (50 mg, intramuscular injection, twice weekly for 16 weeks)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (intramuscular injection, twice weekly for 16 weeks)
Number of subjects: 130
Study: 32556769

Group type: EXPERIMENTAL
Intervention: TAPP (Group 1)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: TEP (Group 2)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: OMH (Group 3)
Number of subjects: 121
Study: 34588198

Group type: EXPERIMENTAL
Intervention: Low-dose inhaled corticosteroids (VDKA trial)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Prospective study of Puerto Rican youth
Number of subjects: 98
Study: 35933275

Group type: EXPERIMENTAL
Intervention: Inactivated quadrivalent influenza vaccine (IIV4) co-administered with the first dose of CoronaVac (C1 subgroup)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Inactivated quadrivalent influenza vaccine (IIV4) co-administered with the second dose of CoronaVac (C2 subgroup)
Number of subjects: 480

Group type: COMPARATOR
Intervention: CoronaVac administered 14 days after the first dose (S group)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Overall comparison of immune response
Number of subjects: 480
Study: 33453450

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks (q2w)
Number of subjects: 2444

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg weekly (qw)
Number of subjects: 2444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2444

Group type: EXPERIMENTAL
Intervention: Dupilumab (both q2w and qw)
Number of subjects: 2444
Study: 32044425

Group type: EXPERIMENTAL
Intervention: Pain-relieved cluster (46.72% in NHRs, 11.71% in home care)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Pain-impaired cluster (22.63% in NHRs, 33.66% in home care)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Severe pain cluster (30.66% in NHRs, 54.63% in home care)
Number of subjects: 342
Study: 35006245

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection
Number of subjects: 97